60 DEGREES PHARMACEUTICALS, INC.: cashflow_investing
| Value | {"amount": -140373, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-06-30 |
| Status | current |
| Entity | 60 DEGREES PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/555c6a2b-ade8-405e-a9b5-fb831d3bc9d0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-24-068673Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946563/cashflow-investing/2024-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/555c6a2b-ade8-405e-a9b5-fb831d3bc9d0
History
- no predecessors — first report